We are regularly recognized as leaders in the biotechnology industry. We also receive recognition and awards for our overall performance as a company, our dynamic workplace culture, our contributions to the community and our patient advocacy. Here are some of our most recent achievements.
In March 2019, Genentech was included on the “Corporate Equality Index” by the Human Rights Campaign Foundation for the thirteenth consecutive year.
Genentech has received a perfect score of 100 percent each year.
In February 2019, Fortune magazine named Genentech one of its “100 Best Companies to Work For” for the twenty-first consecutive year.
In addition to this list, Genentech was listed on Fortune’s:
100 Best Workplaces For Diversity for the third consecutive year.
100 Best Workplaces For Millennials in 2018.
100 Best Workplaces For Women for the second consecutive year.
Top Health Care and Biopharma Companies to Work For for the third consecutive year.
50 Best Workplaces for Giving Back for the third consecutive year.
10 Best Workplaces for Asian-Americans in 2015.
In January 2019, Genentech was named one of the “Best Employers in America for Diversity” by Forbes for the second consecutive year.
Genentech has been honored on this list since its inception in 2018.
In January 2019, MENTOR: The National Mentoring Partnership named Genentech to its “Excellence in Mentoring” list under the impactful philanthropy category.
In November 2018, Genentech received the 2018 Excellence in Business Award for Corporate Social Responsibility from the San Francisco Chamber of Commerce in recognition of our commitment to STEM education.
In November 2018, Sara Kenkare-Mitra, Senior Vice President, Development Sciences, was named one of “2018’s Fiercest Women in Life Sciences” by FiercePharma.
In October 2018, Felipe de Sousa e Melo, Scientist, Discovery Oncology, was named a “2018 STAT Wunderkind” by STAT News.
In October 2018, Genentech was named one of the "Top Twenty Employers" in biotechnology and pharmaceuticals by Science Magazine for the seventeenth consecutive year.
Genentech has been ranked the no. 1 company eight times.
In July 2018, the San Francisco Business Times ranked Genentech no. 6 on its list of "Top Corporate Philanthropists in the Bay Area” for the thirteenth consecutive year.
In July 2018, Genentech was named one of the “50 Companies That Care” by PEOPLE Magazine for the second consecutive year.
Genentech has been honored on this list since its inception in 2017.
In June 2018, Genentech was named one of the “Best Places to Work in IT” by Computerworld for the tenth time.
In June 2018, Genentech was named one of the “50 Best Places to Work for New Dads” by Fatherly for the third time.
In May 2018, Rhona O’Leary, Global Head of Portfolio and Product Development Strategy, and Katie Peng, Senior Vice President, IMPACT Business Unit, were named by the San Francisco Business Times as "Most Influential Women in Business."
The San Francisco Business Times named several previous Genentech honorees to its "Forever Influential" Honor Roll, including Sandra Horning, Chief Medical Officer, Global Head of Product Development; Nancy Vitale, Vice President of Human Resources and Regional HR Head, Pharma North America; and Wendy Young, Vice President, Discovery Chemistry.
Previous winners of this award include Sarah Hymowitz, Vice President and Principal Scientist, Protein Chemistry and Structural Biology (2017), Christy Oliger, Senior Vice President of BioOncology (2017), Carla Boragno, Vice President, Site Services (2016), Amita Joshi, Vice President and Global Head of Clinical Pharmacology (2016), Melissa Starovasnik, Vice President, Protein Sciences (2016), Nancy Vitale, Vice President, Human Resources and Regional Human Resources Head, North America (2015), Wendy Young,Vice President, Small Molecule Discovery Chemistry (2015), and Mary Sliwkowski, Senior Vice President and Global Head of Pharma Technical Regulatory (2014).
In May 2018, Genentech was named one of the “Best Employers in America” by Forbes.
In February 2018, Genentech was named one of the “Most Innovative Companies for Social Good” by Fast Company.
In December 2017, the Nature Index ranked Roche and Genentech no. 2 on its list of the “Top 100 Corporations” based on the output of high-quality science from 2012 to 2016.
Genentech was the highest-ranked biotech or pharmaceutical company on the list.
In May 2017, the American Chemical Society inducted Genentech to the Heroes of Chemistry hall of fame for the discovery and development of the first medicine approved for the treatment of metastatic or locally advanced basal cell carcinoma.
In May 2017, DiversityInc named Genentech to its list of the “Top 50 Companies for Diversity,” as well as its list of the “Top 12 Companies for Employee Resource Groups.”
In August 2016, US2020 awarded Genentech with a STEM Mentoring Award in the Excellence in Public-Private Partnerships category.
In Spring 2016, Woman Engineering Magazine included Genentech on its list of “Top 50 Employers” as part of the Reader’s Choice Awards for the second consecutive year.
In February 2016, Vishva Dixit, Ph.D., Vice President, Physiological Chemistry, received the 2016 Trinity College Dublin Dawson Prize in Genetics for his groundbreaking work on cellular death receptor signaling and inflammation.
In January 2016, Genentech was selected a Top 50 Employer by Equal Opportunity as part of the Reader’s Choice Awards.
In January 2016, MENTOR: The National Mentoring Partnership recognized Genentech in its Corporate Mentoring Challenge Honor Roll.
In January 2016, Joe Arron, M.D, Ph.D., director of Immunology Discovery, was elected to membership in the American Society of Clinical Investigation (ASCI) for his scientific accomplishments that have changed the therapeutic paradigm for the treatment of asthma and, potentially other pulmonary diseases.
Previous elections include Andrew C. Chan, M.D., Ph.D., senior vice president, Research Biology (1999), Vishva M. Dixit, M.D., vice president, Physiological Chemistry (1996), John B. Lowe, Ph.D., senior director, Pathology (1994), and Eric Brown, M.D., vice president, Immunology and Infectious Diseases (1987).